These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2222480)

  • 1. Peroxisomal disorders: complementation analysis using beta-oxidation of very long chain fatty acids.
    McGuinness MC; Moser AB; Moser HW; Watkins PA
    Biochem Biophys Res Commun; 1990 Oct; 172(1):364-9. PubMed ID: 2222480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisomal very long chain fatty acid beta-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression.
    Braiterman LT; Watkins PA; Moser AB; Smith KD
    Mol Genet Metab; 1999 Feb; 66(2):91-9. PubMed ID: 10068511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
    Street JM; Singh H; Poulos A
    Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementation analysis of patients with intact peroxisomes and impaired peroxisomal beta-oxidation.
    McGuinness MC; Moser AB; Poll-The BT; Watkins PA
    Biochem Med Metab Biol; 1993 Apr; 49(2):228-42. PubMed ID: 8484962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.
    Paton BC; Sharp PC; Crane DI; Poulos A
    J Clin Invest; 1996 Feb; 97(3):681-8. PubMed ID: 8609223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdnig-Hoffmann disease.
    Baumgartner MR; Verhoeven NM; Jakobs C; Roels F; Espeel M; Martinez M; Rabier D; Wanders RJ; Saudubray JM
    Neurology; 1998 Nov; 51(5):1427-32. PubMed ID: 9818873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated defect of peroxisomal beta-oxidation in a 16-year-old patient.
    Santer R; Claviez A; Oldigs HD; Schaub J; Schutgens RB; Wanders RJ
    Eur J Pediatr; 1993 Apr; 152(4):339-42. PubMed ID: 8482286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inborn errors of peroxisomal beta-oxidation: a review.
    Wanders RJ; van Roermund CW; Schutgens RB; Barth PG; Heymans HS; van den Bosch H; Tager JM
    J Inherit Metab Dis; 1990; 13(1):4-36. PubMed ID: 2109148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic relationship between the Zellweger syndrome and other peroxisomal disorders characterized by an impairment in the assembly of peroxisomes.
    Tager JM; Brul S; Wiemer EA; Strijland A; Van Driel R; Schutgens RB; Van den Bosch H; Wanders RJ; Westerveld A
    Prog Clin Biol Res; 1990; 321():545-58. PubMed ID: 2183242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.
    Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Heikoop J; van den Bosch H; Schram AW; Tager JM
    J Clin Invest; 1987 Dec; 80(6):1778-83. PubMed ID: 3680527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementation in Zellweger syndrome: biochemical analysis of newly generated peroxisomes.
    Stanczak H; Kremser K; Singh AK; Ashcraft J; Stanley W; Singh I
    Hum Hered; 1992; 42(3):172-8. PubMed ID: 1511996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two siblings with phenotypes mimicking peroxisomal disorders but with discordant biochemical findings.
    Pietrzyk JJ; Turowska-Heydel D; Klimek M; Kaczmarski F; Kaluza J
    Clin Pediatr (Phila); 1990 Aug; 29(8):479-84. PubMed ID: 2208910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins.
    Braiterman LT; Zheng S; Watkins PA; Geraghty MT; Johnson G; McGuinness MC; Moser AB; Smith KD
    Hum Mol Genet; 1998 Feb; 7(2):239-47. PubMed ID: 9425230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fibroblast cell line defective in alkyl-dihydroxyacetone phosphate synthase: a novel defect in plasmalogen biosynthesis.
    Nagan N; Hajra AK; Das AK; Moser HW; Moser A; Lazarow P; Purdue PE; Zoeller RA
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4475-80. PubMed ID: 9114014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new type of peroxisomal disorder with variable expression in liver and fibroblasts.
    Mandel H; Espeel M; Roels F; Sofer N; Luder A; Iancu TC; Aizin A; Berant M; Wanders RJ; Schutgens RB
    J Pediatr; 1994 Oct; 125(4):549-55. PubMed ID: 7931872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudo infantile Refsum's disease: catalase-deficient peroxisomal particles with partial deficiency of plasmalogen synthesis and oxidation of fatty acids.
    Aubourg P; Kremser K; Roland MO; Rocchiccioli F; Singh I
    Pediatr Res; 1993 Sep; 34(3):270-6. PubMed ID: 7510868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction by gene expression of biochemical abnormalities in fibroblasts from Zellweger patients.
    Shimozawa N; Suzuki Y; Tomatsu S; Tsukamoto T; Osumi T; Fujiki Y; Kamijo K; Hashimoto T; Kondo N; Orii T
    Pediatr Res; 1996 May; 39(5):812-5. PubMed ID: 8726233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal diagnosis of inborn errors in peroxisomal beta-oxidation.
    Wanders RJ; Schutgens RB; van den Bosch H; Tager JM; Kleijer WJ
    Prenat Diagn; 1991 Apr; 11(4):253-61. PubMed ID: 1896411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid.
    Moore SA; Hurt E; Yoder E; Sprecher H; Spector AA
    J Lipid Res; 1995 Nov; 36(11):2433-43. PubMed ID: 8656081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient.
    Violante S; Ijlst L; Te Brinke H; Koster J; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
    Biochim Biophys Acta; 2013 Sep; 1831(9):1467-74. PubMed ID: 23850792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.